Alembic Pharmaceuticals

Alembic Pharmaceuticals Limited has informed the Exchange about Schedule of meet

29 Aug, 2025 | 11:14am • Source: NSE

Please find attached herewith the Intimation under Regulation 30 of SEBI LODR Regulations, 2015- Analysts / Investor Meet

29 Aug, 2025 | 10:49am • Source: BSE

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10mg.

19 Aug, 2025 | 11:14am • Source: BSE

As attached.

18 Aug, 2025 | 07:57pm • Source: BSE

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Analysts / Investors Meeting

18 Aug, 2025 | 06:12pm • Source: BSE

Please find attached herewith the Transcript of Post Result Conference Call held on 5th August, 2025

11 Aug, 2025 | 07:36pm • Source: BSE

Newspaper Publications of Unaudited Financials Results

06 Aug, 2025 | 05:33pm • Source: BSE

Please find attached the intimation for appointment of Secretarial Auditors.

05 Aug, 2025 | 11:17pm • Source: BSE

Please find attached the intimation for appointment of Statutory Auditor

05 Aug, 2025 | 11:14pm • Source: BSE

Please find attached the Scrutinizers Report and Voting Result of the AGM

05 Aug, 2025 | 11:01pm • Source: BSE

Please find attached the proceedings of AGM.

05 Aug, 2025 | 10:58pm • Source: BSE

Submission of Audio Recording of Post Results Conference Call held on 5th August, 2025

05 Aug, 2025 | 08:45pm • Source: BSE

Please find the updated Contact details of KMP and senior officials pursuant to Reg 30 (5) of SEBI LODR Regulations, 2015.

05 Aug, 2025 | 01:26pm • Source: BSE

Please find the unaudited financial Results for the quarter ended results 30th June, 2025.

05 Aug, 2025 | 01:21pm • Source: BSE

Please find attached the investor presentation

05 Aug, 2025 | 01:11pm • Source: BSE

Please find attached the Press Release.

05 Aug, 2025 | 01:08pm • Source: BSE

Please find enclosed the Outcome of Board meeting

05 Aug, 2025 | 01:05pm • Source: BSE

Intimation under Regulation 30 of SEBI LODR Regulations, 2015 - Change in Management

31 Jul, 2025 | 06:06pm • Source: BSE

Please find attached herewith the Reaffirmation of Credit Rating on Bank Loan facilities with Enhanced Limits

26 Jul, 2025 | 01:57pm • Source: BSE

Alembic Pharmaceuticals receives USFDA Final approval for Carbamazepine Extended-Release Tablets USP, 100 mg, 200 mg and 400 mg

26 Jul, 2025 | 11:38am • Source: BSE